A new and successful strategy for combating the spread of sexually transmitted diseases such as HIV draws from an old idea: Practice is fundamental to learning, even when it involves using condoms correctly.
A study presented at the American Public Health Association shows the benefits of an exercise program offered by Hospital for Special Surgery in senior centers in New York City's Chinatown and in Flushing, Queens
New research finds improvements in access to care and health outcomes across racial and ethnic groups in Massachusetts since implementation of the state’s health reform law in 2007.
When public health funding increases in a community, its rates of infant mortality and deaths due to preventable diseases decrease over time, with low-income communities experiencing the largest health and economic gains.
Citizenship, particularly for non-U.S. natives, largely determines a woman’s odds of having a mammogram and being screened for cervical and colorectal cancer.
Researchers are reporting positive results from a landmark clinical trial of an investigational aortic valve that is deployed with a catheter, without open heart surgery.
Firearm injuries in the U.S. cost more than $16 billion in hospital resources between 2000 and 2008.
New research finds that the combination of acetaminophen paired with alcohol — even if consumed moderately or lightly — can increase the risk of kidney dysfunction.
New policy changes have led to decreased exposure to environmental tobacco smoke at work, yet workers in some occupations still experience a high prevalence of secondhand smoke
• Kidney disease is a growing public health threat affecting more than 20 million Americans. • Since 1996, the American Society of Nephrology and its foundation have awarded more than $25 million in grants and travel support.
More than half of chronic hepatitis C patients studied in a new research project led by Henry Ford Hospital were not treated for the potentially fatal disease, either because they couldn’t withstand current therapies or because they, or their doctors, were waiting for new treatments.
New drug therapies offer promise to some hepatitis C sufferers whose transplanted livers are threatened by a recurrence of the disease, including some patients who have had no treatment options.
A non-invasive alternative to liver biopsy, now the standard method of diagnosing cirrhosis in hepatitis patients, proved very reliable in a national multi-center study including Henry Ford Hospital.
The risks of developing kidney failure and a calcium deficiency from the popular osteoporosis drug zoledronic acid are extremely rare, according to researchers at Loyola University Health System (LUHS). These findings were presented earlier this month at the American Society for Bone and Mineral Research’s annual meeting.
Experts from NYU Langone’s Department of Medicine, Division of Rheumatology presented new research and participated in expert panel discussions at the American College of Rheumatology 2013 Annual Meeting in San Diego, CA, October 26-30.
Only half of the men who receive a prostate cancer diagnosis in North Carolina consult with more than one type of physician before deciding on a course of treatment, according to research presented by University of North Carolina researchers at the 2013 American Society for Radiation Oncology (ASTRO) annual meeting on Sept. 24.
For women who are at high risk of blood loss, using an artery in the wrist may be better than the groin for routing a stent to the heart during coronary angioplasty, according to researchers at Duke Medicine.
MK-3475, an anti-PD1 immunotherapy drug with promising results in advanced trials in melanoma is also showing potential in lung cancer based on preliminary phase 1b data presented at the 15th World Conference on Lung Cancer in Sydney, Australia. By blocking the PD-1 protein, the drug alerts the immune system to attack the cancer. It is generally well tolerated and further trials in lung cancer are currently underway.
Lower back injuries are the third most common injuries suffered in athletes under age 18. Many injuries are severe enough to sideline young athletes for one-to-six months, and put them at future risk for long-term back problems, a study has found.
For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes--known as the posterior intercostal lymph nodes--that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma.
symptoms and poorer quality of life than older patients, a Mayo Clinic study shows. Fibromyalgia most often strikes women. It is characterized by widespread musculoskeletal pain with fatigue, sleep, memory and mood issues. The research, one of several Mayo studies being presented at the American College of Rheumatology annual meeting, suggests the disorder plays out differently among different age groups.
New research study finds that children ages 1 to 3 years account for one-fifth of all emergency department visits caused by complications from asthma, representing the highest proportion of visits among asthma patients under age 21. In addition, 55 percent of all ED visits due to asthma occur in boys, and fall months – September, October and November – have a relatively high proportion of visits compared to other times of the year. The research was presented at the American Academy of Pediatrics (AAP) National Conference in Orlando. At AAP, the same research team also presented an analysis of adverse drug events (ADE) among hospitalized children in the U.S. from 2003 to 2010. Results reveal that medication errors and ADEs in pediatric inpatient settings gradually increased between 2003 and 2010, although the cause for this increase requires further study.
Two subtypes of human papillomavirus (HPV) prevented by vaccines are half as likely to be found in African-American women as in white women with precancerous cervical lesions, according to researchers at Duke Medicine.
Nanotechnologies are growing in commercial use after more than 20 years of research. This new resource gives the public the best available look at more than 1,600 manufacturer-identified, nanotechnology-based consumer products introduced to the market.
A survey among rheumatologists finds many face moral dilemmas when trying to do what’s best for their patients in the current health care environment.
Urate-lowering therapy alone may not directly reduce the risk of kidney disease in those with hyperuricemia. However, according to a study presented this week at the American College of Rheumatology Annual Meeting in San Diego, working to lower serum uric acid based on the 2012 American College of Rheumatology Guidelines for Management of Gout has a positive effect.
Smoking can increase the effect of inflammation on X-ray damage in people with ankylosing spondylitis by as much as five times. And, the increase is as much as 13 times higher in men with the disease who smoke than women who don’t smoke, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
The number of children and young adults with autoimmune diseases receiving the HPV vaccination is profoundly low despite studies showing the vaccine to be safe and effective, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. Given the increased incidence of HPV in people with autoimmune diseases, this research suggests that increased public health efforts are needed.
Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Rheumatoid arthritis patients who use tumor necrosis factor inhibitors (called Anti-TNFs) to control their disease-related inflammation also have a decreased risk for heart attacks, according to research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Treating rheumatoid arthritis patients with intensive pharmacological agents, such as biologic drugs, may reduce the need for orthopedic joint surgery, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Patients with rheumatoid arthritis may not need to halt use of their antirheumatic drugs prior to surgery due to fears of increased infection risk, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
People with psoriatic arthritis who receive early, aggressive pharmacologic intervention following a treat-to-target approach show better outcomes than those who receive standard care, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Use of a patellofemoral knee brace can improve pain symptoms and bone marrow lesions in patients with a type of osteoarthritis of the knee, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Osteoarthritis patients who engage in regular physical activity have higher Quality- Adjusted Life Years, a standard measurement of quality of life and cost-effectiveness of medical treatment, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
New research presented at the American College of Rheumatology Annual Meeting in San Diego describes an exciting novel tool utilizing telephone linked technology that shows potential as a low cost approach to improving exercise adherence in patients with knee osteoarthritis. The telephone- linked technology acts as an automated physical trainer and behavior therapist to improve adherence to a strengthening protocol for knee osteoarthritis.
Children with juvenile idiopathic arthritis who receive early, aggressive therapy with a combination of medications achieve clinical inactive disease status faster than they would with less aggressive therapy, according to new research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Starting with a combination of three traditional disease-modifying antirheumatic drugs (called DMARDs) for treating early rheumatoid arthritis is more cost-effective long term, with comparable benefits, than using either an immediate or step-up approach with anti-tumor necrosis factor (called Anti-TNFs) drugs and methotrexate, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Using a combination of three traditional disease-modifying antirheumatic drugs for treating recent-onset rheumatoid arthritis is more efficient than a monotherapy approach using methotrexate, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.
Using a combination of three traditional disease-modifying antirheumatic drugs for treating recent-onset rheumatoid arthritis is not only more cost-effective, but results in better long-term worker productivity than a monotherapy approach using methotrexate, according to new research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
A high percentage of rheumatoid arthritis patients discontinue triple therapy, a combination of disease-modifying antirheumatic drugs, after one to two years, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Medicaid beneficiaries with lupus are not adequately following their treatment plans, and this puts them at risk for poor health outcomes, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. For most lupus medications, fewer than one in three beneficiaries were found to be adherent.
According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, researchers have identified three potentially modifiable risk factors and one protective medication that may improve the health of people living with lupus.
According to research presented this week at the American College of Rheumatology Annual Meeting in San Diego, children born to mothers with lupus may be at twice the risk of autism spectrum disorders than those born to mothers without the disease.
Pregabalin (Lyrica® Capsules CV) can significantly improve fibromyalgia pain in people who also are being treated for depression, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Rituximab (Rituxan®) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener’s), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called IgG4-RD), according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Learning that your child has arthritis can lead to a number of questions and concerns about treatment options and prognosis. But, partnering with your child and his or her rheumatologist in shared decision making about their health care can lead to better outcomes overall, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
There has been a progressive decline in the levels of disease activity and disability among children with juvenile idiopathic arthritis over the past 25 years, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. This research confirms the notion that recent advances in the management of the disease have led to a substantial improvement in health outcomes for children living with it.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right